Anzeige
Mehr »
Donnerstag, 05.06.2025 - Börsentäglich über 12.000 News
Kupfer wird knapp! Jetzt mischen sich Medien ein - und ein Explorer liefert die Story zur Fantasie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiRegeneron gains rights to Hansoh's GLP-1/GIP receptor agonist in deal worth $2bn
MiTakeda receives EC approval for Adcetris combination in Hodgkin lymphoma
MiDermaliq and DEBRA partner to advance epidermolysis bullosa drug delivery
MiInizio Evoke appoints Matthew Hoelzle as chief medical officer
MiBuilding inclusive clinical trials through policy reform
MiTurning cold facts into compassionate conversations: the power of patient-centricity in medical education
DiBMS and BioNTech partner on solid tumour candidate in deal worth over $11bn
DiAstraZeneca's Forxiga recommended by NICE for wider chronic kidney disease use
DiRoche/Jazz Pharmaceuticals share positive phase 3 results for lung cancer combination therapy
DiFocusing on the patient voice to improve outcomes
DiHow can we achieve the right balance of HCP engagements in medcomms?
MoPfizer shares 'unprecedented' survival results for Braftovi in colorectal cancer
MoSanofi to expand immunology capabilities with $9.5bn Blueprint Medicines acquisition
MoEli Lilly's Omvoh recommended by NICE to treat Crohn's disease in adults
MoBetween luck and leadership: success because of, not despite, strategy
MoThe evolution of AI in clinical trials: from promise to practice
FrRoche shares positive 96-week results for multiple sclerosis candidate fenebrutinib
FrAstraZeneca receives CHMP recommendation for Imfinzi regimen in bladder cancer
FrSanofi and Stagecoach Performing Arts partner to highlight impact of autoimmune type 1 diabetes
FrUKDRI researchers to evaluate new blood test for neurodegenerative disease diagnosis
FrIn an era of deep uncertainty, life sciences companies require more than agile communications
FrCan we create a world where health is sustainable?
29.05.Biogen and City Therapeutics to develop RNAi therapies in deal worth over $1bn
29.05.Sanofi gains access to Alzheimer's candidate through $470m Vigil acquisition
29.05.The future of customer engagement in biopharma